The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
TCR Therapy-Global Market Insights and Sales Trends 2024
Synopsis
The global TCR Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of TCR Therapy in various end use industries. The expanding demands from the Hospitals, Clinics & Ambulatory Centers, Cancer Research Institutes and Others, are propelling TCR Therapy market. Transduction of Chimeric Antigen Receptor, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Transduction of TCR α/β Heterodimer segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for TCR Therapy market, driven by demand from China, the second largest economy with some signs of stabilising, the TCR Therapy market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for TCR Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global TCR Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global TCR Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, TCR Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of TCR Therapy covered in this report include Adaptimmune Therapeutics PLC, Immunocore, Medigene, Adaptive Biotechnologies, Lion TCR, TCR2 Therapeutics, Inc., RootPath, Kite Pharma and Guangzhou Xiangxue Pharmaceutical Co., Ltd, etc.
The global TCR Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Adaptimmune Therapeutics PLC
Immunocore
Medigene
Adaptive Biotechnologies
Lion TCR
TCR2 Therapeutics, Inc.
RootPath
Kite Pharma
Guangzhou Xiangxue Pharmaceutical Co., Ltd
Eureka Therapeutics
Global TCR Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global TCR Therapy market, Segment by Type:
Transduction of Chimeric Antigen Receptor
Transduction of TCR α/β Heterodimer
Global TCR Therapy market, by Application
Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of TCR Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global TCR Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of TCR Therapy in various end use industries. The expanding demands from the Hospitals, Clinics & Ambulatory Centers, Cancer Research Institutes and Others, are propelling TCR Therapy market. Transduction of Chimeric Antigen Receptor, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Transduction of TCR α/β Heterodimer segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for TCR Therapy market, driven by demand from China, the second largest economy with some signs of stabilising, the TCR Therapy market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for TCR Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global TCR Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global TCR Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, TCR Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of TCR Therapy covered in this report include Adaptimmune Therapeutics PLC, Immunocore, Medigene, Adaptive Biotechnologies, Lion TCR, TCR2 Therapeutics, Inc., RootPath, Kite Pharma and Guangzhou Xiangxue Pharmaceutical Co., Ltd, etc.
The global TCR Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Adaptimmune Therapeutics PLC
Immunocore
Medigene
Adaptive Biotechnologies
Lion TCR
TCR2 Therapeutics, Inc.
RootPath
Kite Pharma
Guangzhou Xiangxue Pharmaceutical Co., Ltd
Eureka Therapeutics
Global TCR Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global TCR Therapy market, Segment by Type:
Transduction of Chimeric Antigen Receptor
Transduction of TCR α/β Heterodimer
Global TCR Therapy market, by Application
Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of TCR Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of TCR Therapy
1.1 TCR Therapy Market Overview
1.1.1 TCR Therapy Product Scope
1.1.2 TCR Therapy Market Status and Outlook
1.2 Global TCR Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global TCR Therapy Market Size by Region (2018-2029)
1.4 Global TCR Therapy Historic Market Size by Region (2018-2023)
1.5 Global TCR Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, TCR Therapy Market Size (2018-2029)
1.6.1 North America TCR Therapy Market Size (2018-2029)
1.6.2 Europe TCR Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific TCR Therapy Market Size (2018-2029)
1.6.4 Latin America TCR Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa TCR Therapy Market Size (2018-2029)
2 TCR Therapy Market by Type
2.1 Introduction
2.1.1 Transduction of Chimeric Antigen Receptor
2.1.2 Transduction of TCR α/β Heterodimer
2.2 Global TCR Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global TCR Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global TCR Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America TCR Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe TCR Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific TCR Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America TCR Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa TCR Therapy Revenue Breakdown by Type (2018-2029)
3 TCR Therapy Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics & Ambulatory Centers
3.1.3 Cancer Research Institutes
3.1.4 Others
3.2 Global TCR Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global TCR Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global TCR Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America TCR Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe TCR Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific TCR Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America TCR Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa TCR Therapy Revenue Breakdown by Application (2018-2029)
4 TCR Therapy Competition Analysis by Players
4.1 Global TCR Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in TCR Therapy as of 2022)
4.3 Date of Key Players Enter into TCR Therapy Market
4.4 Global Top Players TCR Therapy Headquarters and Area Served
4.5 Key Players TCR Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 TCR Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Adaptimmune Therapeutics PLC
5.1.1 Adaptimmune Therapeutics PLC Profile
5.1.2 Adaptimmune Therapeutics PLC Main Business
5.1.3 Adaptimmune Therapeutics PLC TCR Therapy Products, Services and Solutions
5.1.4 Adaptimmune Therapeutics PLC TCR Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Adaptimmune Therapeutics PLC Recent Developments
5.2 Immunocore
5.2.1 Immunocore Profile
5.2.2 Immunocore Main Business
5.2.3 Immunocore TCR Therapy Products, Services and Solutions
5.2.4 Immunocore TCR Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Immunocore Recent Developments
5.3 Medigene
5.3.1 Medigene Profile
5.3.2 Medigene Main Business
5.3.3 Medigene TCR Therapy Products, Services and Solutions
5.3.4 Medigene TCR Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Adaptive Biotechnologies Recent Developments
5.4 Adaptive Biotechnologies
5.4.1 Adaptive Biotechnologies Profile
5.4.2 Adaptive Biotechnologies Main Business
5.4.3 Adaptive Biotechnologies TCR Therapy Products, Services and Solutions
5.4.4 Adaptive Biotechnologies TCR Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Adaptive Biotechnologies Recent Developments
5.5 Lion TCR
5.5.1 Lion TCR Profile
5.5.2 Lion TCR Main Business
5.5.3 Lion TCR TCR Therapy Products, Services and Solutions
5.5.4 Lion TCR TCR Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Lion TCR Recent Developments
5.6 TCR2 Therapeutics, Inc.
5.6.1 TCR2 Therapeutics, Inc. Profile
5.6.2 TCR2 Therapeutics, Inc. Main Business
5.6.3 TCR2 Therapeutics, Inc. TCR Therapy Products, Services and Solutions
5.6.4 TCR2 Therapeutics, Inc. TCR Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 TCR2 Therapeutics, Inc. Recent Developments
5.7 RootPath
5.7.1 RootPath Profile
5.7.2 RootPath Main Business
5.7.3 RootPath TCR Therapy Products, Services and Solutions
5.7.4 RootPath TCR Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 RootPath Recent Developments
5.8 Kite Pharma
5.8.1 Kite Pharma Profile
5.8.2 Kite Pharma Main Business
5.8.3 Kite Pharma TCR Therapy Products, Services and Solutions
5.8.4 Kite Pharma TCR Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Kite Pharma Recent Developments
5.9 Guangzhou Xiangxue Pharmaceutical Co., Ltd
5.9.1 Guangzhou Xiangxue Pharmaceutical Co., Ltd Profile
5.9.2 Guangzhou Xiangxue Pharmaceutical Co., Ltd Main Business
5.9.3 Guangzhou Xiangxue Pharmaceutical Co., Ltd TCR Therapy Products, Services and Solutions
5.9.4 Guangzhou Xiangxue Pharmaceutical Co., Ltd TCR Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Guangzhou Xiangxue Pharmaceutical Co., Ltd Recent Developments
5.10 Eureka Therapeutics
5.10.1 Eureka Therapeutics Profile
5.10.2 Eureka Therapeutics Main Business
5.10.3 Eureka Therapeutics TCR Therapy Products, Services and Solutions
5.10.4 Eureka Therapeutics TCR Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Eureka Therapeutics Recent Developments
6 North America
6.1 North America TCR Therapy Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe TCR Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific TCR Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America TCR Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa TCR Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 TCR Therapy Market Dynamics
11.1 TCR Therapy Industry Trends
11.2 TCR Therapy Market Drivers
11.3 TCR Therapy Market Challenges
11.4 TCR Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
